Related Experiment Video
Updated: Aug 24, 2025

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
Published on: May 3, 2018
A novel site on dual-specificity phosphatase MKP7/DUSP16 is required for catalysis and MAPK binding
Shanelle Shillingford1, Lei Zhang2, Yulia Surovtseva3
1Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut, USA; Department of Chemistry, Yale University, New Haven, Connecticut, USA.
Abstract:
The dual-specificity phosphatases responsible for the inactivation of the mitogen-activated protein kinases (MAPKs) are designated as the MAPK phosphatases (MKPs). We demonstrated previously that MKP5 is regulated through a novel allosteric site suggesting additional regulatory mechanisms of catalysis exist amongst the MKPs. Here, we sought to determine whether the equivalent site within the phosphatase domain of a highly similar MKP family member, MKP7, is also important for phosphatase function. We found that mutation of tyrosine 271 (Y271) in MKP7, which represents the comparable Y435 within the MKP5 allosteric pocket, inhibited MKP7 catalytic activity. Consistent with this, when MKP7 Y271 mutants were overexpressed in cells, the substrates of MKP7, p38 MAPK or JNK, failed to undergo dephosphorylation. The binding efficiency of MKP7 to p38 MAPK and JNK1/2 was also reduced when MKP7 Y271 is mutated. Consistent with reduced MAPK binding, we observed a greater accumulation of nuclear p38 MAPK and JNK when the MKP7 Y271 mutants are expressed in cells as compared with WT MKP7, which sequesters p38 MAPK/JNK in the cytoplasm. Therefore, we propose that Y271 is critical for effective MAPK dephosphorylation through a mechanism whereby binding to this residue precedes engagement of the catalytic site and upon overexpression, MKP7 allosteric site mutants potentiate MAPK signaling. These results provide insight into the regulatory mechanisms of MKP7 catalysis and interactions with the MAPKs. Furthermore, these data support the generality of the MKP allosteric site and provide a basis for small molecule targeting of MKP7.
Insights
Mutation of tyrosine 271 in MAPK phosphatase 7 (MKP7) inhibits its catalytic activity, reducing dephosphorylation of substrates like p38 MAPK and JNK. This highlights Y271
Area of Science:
- Molecular Biology
- Enzymology
- Cell Signaling
Background:
- Mitogen-activated protein kinases (MAPKs) are crucial signaling molecules regulated by MAPK phosphatases (MKPs).
- MKP5 regulation involves a novel allosteric site, suggesting diverse regulatory mechanisms within the MKP family.
Purpose of the Study:
- To investigate the functional importance of an equivalent allosteric site in MKP7, a close relative of MKP5.
- To determine if mutations in this site affect MKP7's catalytic activity and substrate interactions.
Main Methods:
- Site-directed mutagenesis of tyrosine 271 (Y271) in MKP7.
- Assessing MKP7 catalytic activity in vitro.
- Overexpression of wild-type and mutant MKP7 in cells.
- Analyzing substrate (p38 MAPK, JNK) dephosphorylation and cellular localization.
Main Results:
- Mutation of Y271 significantly inhibited MKP7's catalytic activity.
- MKP7 Y271 mutants failed to dephosphorylate p38 MAPK and JNK in cells.
- Binding efficiency of MKP7 to MAPKs was reduced by the Y271 mutation.
- Overexpression of Y271 mutants led to increased nuclear accumulation of p38 MAPK and JNK.
Conclusions:
- Tyrosine 271 is critical for MKP7's dephosphorylation function, likely by mediating substrate binding prior to catalytic site engagement.
- MKP7 allosteric site mutations potentiate MAPK signaling upon overexpression.
- These findings support the generality of the MKP allosteric site and offer a basis for targeting MKP7 with small molecules.
Related Concept Videos
MAPK Signaling Cascades
Microtubule Associated Proteins (MAPs)
PI3K/mTOR/AKT Signaling Pathway
Microtubule Instability
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Inhibition of Cdk Activity

